Advancements in the field of targeted gene inactivation aimed towards the eradication of cancer cells and their processes have provided new avenues for the development of highly specific therapies.
Our drug development program is focused on creating novel therapeutic agents and drug delivery systems that specifically target CSCs and inhibit tumor related stem cell pathways. Our unique candidate compounds act via regulation of microRNA (miRNA) dependent oncogenic and tumor suppressor pathways.
COARE’s research based approach attempts to understand the underlying mechanisms that control tumor initiation, progression and metastasis. We are dedicated to developing the highest quality anti-cancer agents with the goal of eradicating cancer within our lifetime.